Vivos Therapeutics, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VVOS research report →
Companyvivos.com
Vivos Therapeutics, Inc. , a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring.
- CEO
- R. Kirk Huntsman
- IPO
- 2020
- Employees
- 109
- HQ
- Highlands Ranch, CO, US
Price Chart
Valuation
- Market Cap
- $3.47M
- P/E
- -0.34
- P/S
- 0.18
- P/B
- -7.59
- EV/EBITDA
- -0.60
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 61.80%
- Op Margin
- -113.15%
- Net Margin
- -128.01%
- ROE
- -2233.03%
- ROIC
- -145.22%
Growth & Income
- Revenue
- $17.44M · 16.05%
- Net Income
- $-21,230,000 · -90.64%
- EPS
- $-2.06 · 7.21%
- Op Income
- $-19,894,000
- FCF YoY
- -32.77%
Performance & Tape
- 52W High
- $7.95
- 52W Low
- $0.57
- 50D MA
- $1.03
- 200D MA
- $2.27
- Beta
- 6.21
- Avg Volume
- 221.43K
Get TickerSpark's AI analysis on VVOS
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 31, 26 | V-Co Investors 3 LLC | other | 0 |
| Mar 31, 26 | V-Co Investors 3 LLC | other | 429,957 |
| Mar 31, 26 | V-Co Investors 3 LLC | other | 1,783,582 |
| Mar 31, 26 | V-Co Investors 3 LLC | other | 1,783,582 |
| Mar 31, 26 | Skaff Michael C | buy | 1,783,582 |
| Mar 31, 26 | Skaff Michael C | buy | 1,783,582 |
| Mar 31, 26 | Skaff Michael C | buy | 308,848 |
| Mar 31, 26 | Skaff Michael C | buy | 1,044,777 |
| Mar 31, 26 | Skaff Michael C | buy | 429,957 |
| Feb 4, 26 | JOHNSON GREGG C | other | 0 |
Our VVOS Coverage
We haven't published any research on VVOS yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate VVOS Report →